#1 Clinical Trials Search in Europe

Pioglitazone Hydrochloride

This article examines the use of Pioglitazone Hydrochloride, a medication primarily used to treat type 2 diabetes, in various clinical trials. These studies explore its potential benefits in conditions such as head and neck cancer prevention, severe sepsis, asthma, and its interactions with other drugs. The trials aim to assess the drug’s efficacy, safety, and pharmacokinetics in different patient populations.

Table of Contents

What is Pioglitazone Hydrochloride?

Pioglitazone Hydrochloride, also known by its brand name Actos, is a medication primarily used to treat type 2 diabetes mellitus. It belongs to a class of drugs called thiazolidinediones, which are also known as “insulin sensitizers”[1]. This medication helps to control blood sugar levels in people with diabetes by making the body more sensitive to its own insulin, a hormone that regulates blood sugar.

Uses of Pioglitazone Hydrochloride

The primary use of Pioglitazone Hydrochloride is in the treatment of type 2 diabetes. However, research is ongoing to explore its potential benefits in other conditions. Here are the main uses and areas of research:

  • Type 2 Diabetes Mellitus: Pioglitazone is used either alone or in combination with other diabetes medications to help control blood sugar levels in adults with type 2 diabetes[2].
  • Polycystic Ovary Syndrome (PCOS): Some studies have investigated the use of Pioglitazone in women with PCOS to help regulate menstrual cycles and reduce symptoms of hyperandrogenism (excess male hormones)[1].
  • Chronic Myeloid Leukemia (CML): Research is being conducted to explore whether Pioglitazone could be beneficial in treating certain types of leukemia, particularly chronic myeloid leukemia[3].
  • Asthma: Some researchers are investigating whether Pioglitazone could help reduce inflammation and improve symptoms in people with allergic asthma who don’t respond well to standard treatments[4].
  • Cancer Prevention: Studies are exploring the potential of Pioglitazone in preventing certain types of cancer, such as lung cancer and head and neck cancer[5][6].

How Pioglitazone Works

Pioglitazone Hydrochloride works by activating a specific protein in your cells called peroxisome proliferator-activated receptor-gamma (PPAR-gamma). This protein helps regulate how your body processes glucose (sugar) and fats. By activating PPAR-gamma, Pioglitazone:

  • Increases your body’s sensitivity to insulin, allowing it to use insulin more effectively
  • Reduces the amount of glucose produced by your liver
  • Helps your body store fat more effectively, which can improve cholesterol levels

These effects combine to lower blood sugar levels in people with type 2 diabetes[2].

Dosage and Administration

Pioglitazone Hydrochloride is typically taken orally (by mouth) once daily. The dosage can vary depending on the condition being treated and the individual patient’s needs. Here are some common dosages used in clinical trials:

  • For Type 2 Diabetes: Doses ranging from 15 mg to 45 mg once daily have been studied[2].
  • For PCOS: A dose of 30 mg daily, potentially increased to 45 mg after 2 months, has been investigated[1].
  • For other conditions: Dosages may vary and should be determined by a healthcare provider.

It’s important to take Pioglitazone exactly as prescribed by your doctor. Do not change your dose or stop taking the medication without consulting your healthcare provider.

Potential Side Effects

Like all medications, Pioglitazone Hydrochloride can cause side effects. Some of the most common side effects include:

  • Fluid retention and weight gain: This can sometimes lead to or worsen heart failure in some patients.
  • Increased risk of bone fractures, particularly in women.
  • Bladder cancer: There may be a slightly increased risk, although this is rare.
  • Low blood sugar (hypoglycemia), especially when used with other diabetes medications.
  • Upper respiratory tract infection
  • Headache
  • Muscle pain (myalgia)

It’s important to discuss all potential risks and side effects with your healthcare provider before starting Pioglitazone[2][7].

Ongoing Research and Potential New Uses

Researchers are continually studying Pioglitazone to understand its full potential. Some areas of ongoing research include:

  • Asthma treatment: Studies are investigating whether Pioglitazone could help reduce airway inflammation and improve symptoms in people with allergic asthma[4].
  • Cancer prevention: Research is exploring the potential of Pioglitazone in preventing certain types of cancer, including lung cancer and oral cancers[5][6].
  • Leukemia treatment: Some studies are looking at whether Pioglitazone could be beneficial in treating certain types of leukemia, particularly chronic myeloid leukemia[3].
  • Sepsis treatment: Researchers are investigating whether Pioglitazone could help reduce inflammation in patients with severe sepsis and septic shock[7].

It’s important to note that these are areas of ongoing research, and Pioglitazone is not currently approved for these uses. Always consult with your healthcare provider about the most appropriate treatments for your specific condition.

Study Focus Patient Population Dosage Key Outcomes Measured
Head and Neck Cancer Prevention Patients with oral leukoplakia Not specified Reversal of leukoplakia, safety and tolerability
Severe Sepsis Treatment Adolescents aged 12-17 with severe sepsis 0.5 mg/kg/dose for 5 days Pharmacokinetics, effect on inflammatory biomarkers
Type 2 Diabetes Management Adults with type 2 diabetes 15 mg, 30 mg, or 45 mg daily Changes in HbA1c, fasting plasma glucose, lipid profiles
Asthma Treatment Adults with allergic asthma Not specified Change in airflow obstruction, airway inflammation
Drug Interaction Studies Healthy adult volunteers 15 mg Pharmacokinetics when combined with other drugs

FAQ

  • What is Pioglitazone Hydrochloride used for in these clinical trials? Pioglitazone Hydrochloride is being studied for various conditions, including preventing head and neck cancer in patients with oral leukoplakia, treating severe sepsis and septic shock in adolescents, managing type 2 diabetes, and potentially treating asthma.
  • How does Pioglitazone Hydrochloride work? Pioglitazone Hydrochloride is a PPAR-gamma agonist, which means it activates certain proteins that help regulate blood sugar levels and fat storage. In diabetes, it helps improve insulin sensitivity. In other conditions, it may have anti-inflammatory effects.
  • Are there any side effects of Pioglitazone Hydrochloride mentioned in these trials? While specific side effects aren't detailed in the provided information, the trials are monitoring for adverse events. One study specifically looks at hypoglycemic events as a safety measure. As with any medication, side effects are possible and are being carefully evaluated in these trials.
  • How is Pioglitazone Hydrochloride administered in these trials? In most of the trials, Pioglitazone Hydrochloride is administered orally, either as tablets or capsules. The dosage varies depending on the study, ranging from 15 mg to 45 mg, typically taken once daily.
  • What are some of the outcomes being measured in these Pioglitazone Hydrochloride trials? The trials are measuring various outcomes, including changes in blood glucose levels, insulin sensitivity, lipid profiles, inflammatory markers, and specific disease-related markers. Some studies are also looking at the drug's pharmacokinetics, which is how the body processes the medication.

Ongoing Clinical Trials on Pioglitazone Hydrochloride

  • Study on Pamapimod and Pioglitazone for COVID-19 Recovery in Non-Hospitalized Patients

    Not recruiting

    1
    Investigated diseases:
    Investigated drugs:
    Germany

Glossary

  • Pioglitazone Hydrochloride: A medication primarily used to treat type 2 diabetes. It belongs to a class of drugs called thiazolidinediones, which help improve insulin sensitivity in the body.
  • Oral Leukoplakia: A condition characterized by white patches on the gums, inside of the cheeks, and sometimes on the tongue. It's often considered a precancerous condition.
  • Severe Sepsis: A serious complication of infection where the body's response to infection causes widespread inflammation and can lead to organ failure.
  • Pharmacokinetics: The study of how a drug moves through the body, including how it's absorbed, distributed, metabolized, and excreted.
  • PPAR-gamma: Peroxisome Proliferator-Activated Receptor gamma, a protein involved in regulating glucose metabolism and fat storage in the body.
  • Glycosylated Hemoglobin (HbA1c): A form of hemoglobin used to test average blood glucose levels over the past 2-3 months.
  • Fasting Plasma Glucose (FPG): The level of glucose in the blood after not eating or drinking for at least 8 hours.
  • Lipid Profile: A blood test that measures different types of fats in the blood, including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.
  • Insulin Sensitivity: How responsive the body's cells are to insulin. Improved insulin sensitivity means cells can use glucose from the blood more effectively.
  • Biomarker: A measurable indicator of a biological state or condition, often used to track the progress of a disease or the effects of treatment.

References

  1. https://clinicaltrials.gov/study/NCT03757923
  2. https://clinicaltrials.gov/study/NCT05028140
  3. https://clinicaltrials.gov/study/NCT02767063
  4. https://clinicaltrials.gov/study/NCT00604578
  5. https://clinicaltrials.gov/study/NCT00780234
  6. https://clinicaltrials.gov/study/NCT00099021
  7. https://clinicaltrials.gov/study/NCT01352182